Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Bone Marrow Transplant ; 27(11): 1125-32, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11551022

RESUMEN

Mobilised peripheral blood stem cells are widely used for autografting in patients with chronic myeloid leukaemia (CML) and it is generally thought that a high proportion of Ph-negative progenitor cells in the graft is desirable. We report here the results of 91 stem cell mobilisations performed with various chemotherapy regimens followed by G-CSF. We show that mobilisation of Ph-negative cells is possible after diagnosis as well as in advanced stages of the disease. The yield of Ph-negative cells is highly dependent on the chemotherapy regimen: while the combination of idarubicin and cytarabin for 3-5 days (IC3-5) mobilised Ph-negative cells in most patients, high-dose cyclophosphamide was ineffective. Mobilisation of Ph-negative progenitor cells after IC3 was at least as effective as after IC5; however, less apheresis sessions were required, and toxicity was much reduced after IC3. Compared to historical controls, IC was equally effective as the widely used ICE/miniICE (idarubicin, cytarabin, etoposide) protocol. No correlation was found between graft quality and the cytogenetic response to subsequent treatment with interferon-alpha. We conclude that IC3 is an effective and well-tolerated regimen for mobilising Ph-negative cells that compares well with more aggressive approaches such as IC5 and ICE/miniICE.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Movilización de Célula Madre Hematopoyética/métodos , Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Leucemia Mielógena Crónica BCR-ABL Positiva/terapia , Adolescente , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Ciclofosfamida/administración & dosificación , Ciclofosfamida/normas , Ciclofosfamida/toxicidad , Citarabina/administración & dosificación , Citarabina/normas , Citarabina/toxicidad , Femenino , Supervivencia de Injerto/efectos de los fármacos , Factor Estimulante de Colonias de Granulocitos/administración & dosificación , Factor Estimulante de Colonias de Granulocitos/normas , Factor Estimulante de Colonias de Granulocitos/toxicidad , Movilización de Célula Madre Hematopoyética/normas , Humanos , Idarrubicina/administración & dosificación , Idarrubicina/normas , Idarrubicina/toxicidad , Interferón-alfa/administración & dosificación , Leucaféresis/normas , Masculino , Persona de Mediana Edad , Cromosoma Filadelfia
2.
Anesth Prog ; 44(3): 90-5, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9481968

RESUMEN

The purpose of this study was to investigate the ability of low-dose fentanyl to produce analgesia when administered via the periodontal ligament injection in teeth with symptomatic, inflamed pulps. All subjects presented for emergency treatment with moderate to severe pain and had a posterior tooth with a clinical diagnosis of irreversible pulpitis. Twenty subjects randomly received either 10 micrograms fentanyl citrate or saline placebo via the periodontal ligament injection in a double-blind manner. The subjects rated their pain prior to injection and rated pain intensity and pain half gone for 59 min postinjection. Low-dose fentanyl delivered via the periodontal ligament injection in inflamed teeth provided significantly greater analgesia than the saline placebo (P < 0.05). Since the dose of fentanyl used was less than the dose required to provide analgesia by a central mechanism, the results of this study may be consistent with a peripheral opioid mechanism of action.


Asunto(s)
Analgesia/métodos , Analgésicos Opioides/administración & dosificación , Anestesia Dental/métodos , Fentanilo/administración & dosificación , Pulpitis/terapia , Adulto , Método Doble Ciego , Femenino , Humanos , Inyecciones , Masculino , Dimensión del Dolor , Ligamento Periodontal , Factores de Tiempo
3.
Artículo en Inglés | MEDLINE | ID: mdl-2410330

RESUMEN

Mononuclear cells (MNC) of 17 patients suffering from B chronic lymphocytic leukemia (B-CLL) were analysed by various immunological methods. The B cell nature of CLL cell was determined by classical tests (MRBC-rosette-test, immunofluorescence test for detection of membrane bound immunoglobulins). The cytochemical detection of the new T-cell marker dipeptidyl peptidase IV (DP IV) was found to be suitable for the characterization of B-CLL. The B-CLL cells showed granular pattern of alpha-naphthylacetate esterase (ANAE) reaction and binding of the monoclonal pan T antibody BL-T2. These non typical reactions for normal B lymphocytes can be used for differential diagnosis of B-CLL in combination with other reliable T cell markers. Avoiding the separation of T cells, the mixed rosette assay was used to enumerate Fc-IgG-receptor bearing T(TG) and non T cells. Both cell populations were found to be significantly elevated in MNC of B-CLL.


Asunto(s)
Linfocitos B/inmunología , Leucemia Linfoide/inmunología , Anciano , Anticuerpos Monoclonales/inmunología , Humanos , Persona de Mediana Edad , Naftol AS D Esterasa/metabolismo , Formación de Roseta , Linfocitos T/clasificación , Linfocitos T/enzimología , Linfocitos T/inmunología
5.
Z Gesamte Inn Med ; 31(13): 490-3, 1976 Jul 01.
Artículo en Alemán | MEDLINE | ID: mdl-960871

RESUMEN

In order to recognize courses with high and low progression in rheumatoid arthritis deviating from former approach the values of a locomotor function test were used which do not belong to the dispersion region for the adequate classes of duration of a disease. With the help of a material of an electronic data processing study of 1,000 cases with ascertained diagnosis correlations between high progression and, among others, following criteria could be ascertained: male sex, old age, early beginning of the disease, manual trades, unfavourable functional values and very much changed laboratory values including high titres of the rheumatoid factor. In this method there was no relation to the duration of the disease, as it was existing with other methods of the determination of progression which were comparatively included into the investigation.


Asunto(s)
Artritis Reumatoide/complicaciones , Adulto , Factores de Edad , Formación de Anticuerpos , Artritis Reumatoide/inmunología , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Trastornos del Movimiento/etiología , Pronóstico , Factor Reumatoide/aislamiento & purificación , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA